Patents by Inventor Jerzy Olejnik

Jerzy Olejnik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11940413
    Abstract: The invention provides methods and compositions, including, without limitation, algorithms, computer readable media, computer programs, apparatus, and systems for determining the identity of nucleic acids in nucleotide sequences using, for example, data obtained from sequencing by synthesis methods. A plurality of smaller flow cells is employed, each with a relatively small area to be imaged, in order to provide greater flexibility and efficiency.
    Type: Grant
    Filed: March 8, 2021
    Date of Patent: March 26, 2024
    Assignee: IsoPlexis Corporation
    Inventors: Steven Gordon, Thomas Hagerott, Edmund Golaski, Jerzy Olejnik
  • Publication number: 20240093164
    Abstract: The present invention relates to a polymerase enzyme from 9° N with improved ability to incorporate reversibly terminating nucleotides. The enzyme comprising mutations in the motif A region. The invention also relates to methods of using such enzymes as well as a kit with such polymerases.
    Type: Application
    Filed: November 27, 2023
    Publication date: March 21, 2024
    Inventors: Jerzy OLEJNIK, Angela DELUCIA
  • Publication number: 20240076731
    Abstract: The invention provides methods and compositions, including, without limitation, algorithms, computer readable media, computer programs, apparatus, and systems for determining the identity of nucleic acids in nucleotide sequences using, for example, data obtained from sequencing by synthesis methods. The methods of the invention include correcting one or more phenomena that are encountered during nucleotide sequencing, such as using sequencing by synthesis methods. These phenomena include, without limitation, sequence lead, sequence lag, spectral crosstalk, and noise resulting from variations in illumination and/or filter responses.
    Type: Application
    Filed: March 3, 2023
    Publication date: March 7, 2024
    Inventors: Steven GORDON, Jerzy OLEJNIK
  • Publication number: 20240060128
    Abstract: The invention provides methods and compositions, including, without limitation, algorithms, computer readable media, computer programs, apparatus, and systems for determining the identity of nucleic acids in nucleotide sequences using, for example, data obtained from sequencing by synthesis methods. The methods of the invention include correcting one or more phenomena that are encountered during nucleotide sequencing, such as using sequencing by synthesis methods. These phenomena include, without limitation, sequence lead, sequence lag, spectral crosstalk, and noise resulting from variations in illumination and/or filter responses.
    Type: Application
    Filed: July 28, 2023
    Publication date: February 22, 2024
    Inventors: Steven GORDON, Jerzy OLEJNIK
  • Patent number: 11866741
    Abstract: The present invention relates to a polymerase enzyme from 9° N with improved ability to incorporate reversibly terminating nucleotides. The enzyme comprising mutations in the motif A region. The invention also relates to methods of using such enzymes as well as a kit with such polymerases.
    Type: Grant
    Filed: June 17, 2021
    Date of Patent: January 9, 2024
    Assignee: IsoPlexis Corporation
    Inventors: Jerzy Olejnik, Angela Delucia
  • Publication number: 20230407384
    Abstract: The invention provides methods and compositions, including, without limitation, algorithms, computer readable media, computer programs, apparatus, and systems for determining the identity of nucleic acids in nucleotide sequences using, for example, data obtained from sequencing by synthesis methods. The methods of the invention include correcting one or more phenomena that are encountered during nucleotide sequencing, such as using sequencing by synthesis methods. These phenomena include, without limitation, sequence lead, sequence lag, spectral crosstalk, and noise resulting from variations in illumination and/or filter responses.
    Type: Application
    Filed: May 30, 2023
    Publication date: December 21, 2023
    Inventors: Steven GORDON, Jerzy OLEJNIK
  • Patent number: 11548909
    Abstract: The present invention provides methods, compositions, mixtures and kits utilizing deoxynucleoside triphosphates comprising a 3?-O position capped by a group comprising methylenedisulfide as a cleavable protecting group and a detectable label reversibly connected to the nucleobase of said deoxynucleoside. Such compounds provide new possibilities for future sequencing technologies, including but not limited to Sequencing by Synthesis.
    Type: Grant
    Filed: March 22, 2018
    Date of Patent: January 10, 2023
    Assignee: IsoPlexis Corporation
    Inventors: Mong Sano Marma, Jerzy Olejnik, Ilia Korboukh
  • Patent number: 11359237
    Abstract: Modular flow cells, devices with modular flow cells, and methods of sequencing using modular flow cells, as well as systems and kits including modular flow cells, are described, permitting sequencing wherein less than the full capacity for sequencing is desired.
    Type: Grant
    Filed: April 23, 2020
    Date of Patent: June 14, 2022
    Assignees: QIAGEN SCIENCES, LLC, QIAGEN GmbH
    Inventors: Jerzy Olejnik, Dirk Zimmermann
  • Publication number: 20220177859
    Abstract: The present invention relates to a polymerase enzyme with improved ability to incorporate reversibly terminating nucleotides. The enzyme comprising the following mutations in the motif A region (SGS). It relates to a polymerase enzyme according to SEQ ID NO. 1 or any polymerase that shares at least 70% amino acid sequence identity thereto, comprising a mutation selected from the group of (i) at position 412 of SEQ ID NO. 1: serine (S) (L412S) and/or, (ii) at position 413 of SEQ ID NO. 1: glycine (G) (Y413G) and/or (iii) at position 414 of SEQ ID NO. 1: serine (S) (P414S), wherein the enzyme has little or no 3?-5? exonuclease activity.
    Type: Application
    Filed: February 13, 2018
    Publication date: June 9, 2022
    Inventors: Jerzy Olejnik, Angela Delucia, Ralf Peist, Nicole Grasse
  • Publication number: 20220162251
    Abstract: The present invention provides methods, compositions, mixtures and kits utilizing deoxynucleoside triphosphates comprising a 3?-O position capped by a group comprising methylenedisulfide as a cleavable protecting group and a detectable label reversibly connected to the nucleobase of said deoxynucleoside. Such compounds provide new possibilities for future sequencing technologies, including but not limited to Sequencing by Synthesis.
    Type: Application
    Filed: June 28, 2021
    Publication date: May 26, 2022
    Inventors: Mong Sano MARMA, Jerzy Olejnik, Ilia Korboukh
  • Publication number: 20220162689
    Abstract: The present invention is related to DNA/RNA sequencing and in particular approaches termed Next Generation Sequencing (NGS). Improved methods and integrated devices are disclosed, which enable faster and more efficient analysis of nucleic acids. One aspect of the invention has to do with integration of detection system into consumable flowcell. This enables miniaturization and simplification of sequencing instrumentation while simultaneously reducing sequencing costs. By performing sequencing and detection directly on the sensor, such as CCD or CMOS, one can significantly speed up the sequencing process.
    Type: Application
    Filed: November 23, 2020
    Publication date: May 26, 2022
    Inventors: Michel Perbost, Jerzy Olejnik
  • Publication number: 20220145272
    Abstract: The present invention relates to a polymerase enzyme with improved ability to incorporate reversibly terminating nucleotides. The enzyme comprising the following mutations in the motif A region (SGS). It relates to a polymerase enzyme according to SEQ ID NO. 1 with mutations in the amino acid sequence positions 409, 410 and 411.
    Type: Application
    Filed: February 13, 2018
    Publication date: May 12, 2022
    Inventors: Jerzy Olejnik, Angela Delucia, Cheng-yao Chen, Ryan Charles Heller, Thomas William Schoenfeld
  • Publication number: 20220127587
    Abstract: The present invention relates to a polymerase enzyme from Pyrococcus furiosus with improved ability to incorporate reversibly terminating nucleotides. The enzyme comprising the following mutations in the motif A region (SGS). It relates to a polymerase enzyme according to SEQ ID NO. 1 or any polymerase that shares at least 70% amino acid sequence identity thereto, comprising a mutation selected from the group of (i) at position 409 of SEQ ID NO. 3: serine (S) (L409S) and/or, (ii) at position 410 of SEQ ID NO. 3: glycine (G) (Y410G) and/or (iii) at position 411 of SEQ ID NO. 3: serine (S) (P411S), wherein the enzyme has little or no 3?-5? exonuclease activity.
    Type: Application
    Filed: February 13, 2018
    Publication date: April 28, 2022
    Inventors: Jerzy Olejnik, Angela Delucia, Cheng-yao Chen, Ryan Charles Heller, Thomas William Schoenfeld
  • Publication number: 20210355529
    Abstract: The invention relates to methods, compositions, devices, systems and kits as described including, without limitation, reagents and mixtures for determining the identity of nucleic acids in nucleotide sequences using, for example, sequencing by synthesis methods. In particular, the present invention contemplates the use of polyphenolic compounds, known as antioxidant additives, to improve the efficiency of Sequencing-By-Synthesis reactions. For example, gallic acid (GA) is shown herein to be one of many exemplary SBS polyphenolic additives.
    Type: Application
    Filed: July 28, 2021
    Publication date: November 18, 2021
    Inventors: Jerzy OLEJNIK, Michel Georges PERBOST
  • Publication number: 20210317423
    Abstract: The present invention relates to a polymerase enzyme from 9° N with improved ability to incorporate reversibly terminating nucleotides. The enzyme comprising mutations in the motif A region. The invention also relates to methods of using such enzymes as well as a kit with such polymerases.
    Type: Application
    Filed: June 17, 2021
    Publication date: October 14, 2021
    Inventors: Jerzy Olejnik, Angela Delucia
  • Patent number: 11117921
    Abstract: The present invention provides methods, compositions, mixtures and kits utilizing deoxynucleoside triphosphates comprising a 3?-O position capped by a group comprising methylenedisulfide as a cleavable protecting group and a detectable label reversibly connected to the nucleobase of said deoxynucleoside. Such compounds provide new possibilities for future sequencing technologies, including but not limited to Sequencing by Synthesis.
    Type: Grant
    Filed: May 28, 2019
    Date of Patent: September 14, 2021
    Assignee: IsoPlexis Corporation
    Inventors: Mong Sano Marma, Jerzy Olejnik, Ilia Korboukh
  • Patent number: 11078526
    Abstract: The invention relates to methods, compositions, devices, systems and kits as described including, without limitation, reagents and mixtures for determining the identity of nucleic acids in nucleotide sequences using, for example, sequencing by synthesis methods. In particular, the present invention contemplates the use of polyphenolic compounds, known as antioxidant additives, to improve the efficiency of Sequencing-By-Synthesis reactions. For example, gallic acid (GA) is shown herein to be one of many exemplary SBS polyphenolic additives.
    Type: Grant
    Filed: May 24, 2019
    Date of Patent: August 3, 2021
    Assignee: IsoPlexis Corporation
    Inventors: Jerzy Olejnik, Michel Georges Perbost
  • Publication number: 20210230686
    Abstract: The invention provides methods and compositions, including, without limitation, algorithms, computer readable Media, computer programs, apparatus, and systems for determining the identity of nucleic acids in nucleotide sequences using, for example, data obtained from sequencing by synthesis methods. The methods of the invention include correcting one or more phenomena that are encountered during nucleotide sequencing, such as using sequencing by synthesis methods. These phenomena include, without limitation, sequence lead, sequence lag, spectral crosstalk, and noise resulting from variations in illumination and/or filter responses.
    Type: Application
    Filed: March 30, 2021
    Publication date: July 29, 2021
    Inventors: Steven Gordon, Jerzy Olejnik
  • Publication number: 20210231609
    Abstract: The invention provides methods and compositions, including, without limitation, algorithms, computer readable media, computer programs, apparatus, and systems for determining the identity of nucleic acids in nucleotide sequences using, for example, data obtained from sequencing by synthesis methods. A plurality of smaller flow cells is employed, each with a relatively small area to be imaged, in order to provide greater flexibility and efficiency.
    Type: Application
    Filed: March 8, 2021
    Publication date: July 29, 2021
    Inventors: Steven Gordon, Thomas Hagerott, Edmund Golaski, Jerzy Olejnik
  • Patent number: 11046726
    Abstract: The present invention provides methods, compositions, mixtures and kits utilizing deoxynucleoside triphosphates comprising a 3?-O position capped by a group comprising methylenedisulfide as a cleavable protecting group and a detectable label reversibly connected to the nucleobase of said deoxynucleoside. Such compounds provide new possibilities for future sequencing technologies, including but not limited to Sequencing by Synthesis.
    Type: Grant
    Filed: March 22, 2018
    Date of Patent: June 29, 2021
    Assignee: QIAGEN SCIENCES, LLC
    Inventors: Mong Sano Marma, Jerzy Olejnik, Ilia Korboukh